logo-loader

Arecor

Receive alerts
Market:
Unlisted (UK)
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform.

Deep dive We explore the investor case for growth companies

Snapshot

  • Biopharmaceuticals company developing superior diabetes care
  • Developing portfolio of of diabetes care treatments
  • Successfully completed phase I trial for ultra-rapid acting insulin

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Arecor punches above its weight with trials for fast-acting diabetes drugs

Investors are placing bets on a small British biotech to rival big pharma as it pushes its first diabetes drug through clinical trials

on 14/11/19